Home › NCT06843330
Accuracy of Lactate Meter in GSDIa
Are Portable Lactate Monitoring Devices Accurate in Patients With Glycogen Storage Disease Ia When Compared to Blood Serum Lactates?
Who can join
Ages 0 to 60 · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients with diagnosed/confirmed (by liver biopsy or genetic testing) Glycogen Storage Disease Type Ia (ICD 10 code: E74.01). * Connecticut Children's Emergency Department visit and/or admission to Connecticut Children's during time study is active * For pediatric participants: Ability of child's parent/legal guardian to understand and the willingness to sign a written informed consent document * For adults: Ability to understand and the willingness to sign a written informed consent Exclusion Criteria: * Patients with Glycogen storage disease unspecified 74.00, or Ib * Patients not meeting inclusion criteria
About the study
The goal of this observational study is to determine if home lactate meters (both capillary and serum sample) are accurate, compared to lab serum lactate in a population of patients with glycogen storage disease type 1a and to determine if the Accu Chek Guide glucometer (capillary sample) is accurate, in a population of patients with glycogen storage disease type 1a.
What is being tested
- blood glucose meter; blood lactate meter (device)
Sponsor: Connecticut Children's Medical Center · Participants: 10 · Started: Apr 14, 2025
Contact the study team
- Malaya Mount, MS, RD · Phone: 860-837-6700
- Rebecca Riba-Wolman, MD · Phone: 860-837-6700
Official record on ClinicalTrials.gov — NCT06843330
Locations in the U.S.
| Connecticut | Connecticut Children's Medical Center, Hartford |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.